BCFS001413-UTHSC-Cowan-172 [Landing Page] -

Meth Use Research Study

Researchers at The University of Tennessee Health Science Center are conducting a study to learn more about the effectiveness of two medications as treatments for meth addiction.

Fast Facts

Study Background

Help us learn more about potential treatments for meth addiction.

The purpose of this study is to investigate the combination of naltrexone injections and bupropion tablets as treatments for methamphetamine use disorder.

If you are eligible and choose to participate, you may receive these medications or a placebo.

No judgment. Everything will be kept confidential.

Study Background

Help us learn more about potential treatments for meth addiction.

The purpose of this study is to investigate the combination of naltrexone injections and bupropion tablets as treatments for methamphetamine use disorder.

If you are eligible and choose to participate, you may receive these medications or a placebo.

No judgment. Everything will be kept confidential.

Additional Information

Why is this study being done?

The purpose of this study is to investigate the combination of two medications (naltrexone injections and bupropion tablets) as treatments for methamphetamine use disorder.

Is this study for me?

You may qualify for this study if you meet the following criteria:

Inclusion Criteria:

Ages 18-65
Currently use meth and interested in reducing or stopping use
Able to commit to attending in-person visits on site in Memphis, TN

What will happen if I participate in the study?

This study will last approximately 19 weeks, and will include 1-2 in-person visits per week.

If eligible, you will either receive the combination of naltrexone injections and bupropion tablets, or a placebo. During the treatment period, you will be asked to submit daily videos of yourself taking the medication. You will also be asked to complete: